What do the San Diego Comic-Con and multiple myeloma have in common? Does that sound like a very strange question? Am I still stuck…

Most myeloma patients taking Tecvayli (teclistamab-cqyv) were alive and free from disease progression two years after starting treatment, according to a new analysis…

A large, late-stage clinical trial testing an immunotherapy in people with gynecological cancers is recruiting participants ahead of schedule, even amid the typically slower…